Cargando…
Translational Medicine: Towards Gene Therapy of Marfan Syndrome
Marfan syndrome (MFS) is one of the most common inherited disorders of connective tissue caused by mutations of the fibrillin-1 gene (FBN1). Vascular abnormalities, such as the enlargement of the aorta with the risk of life-threatening rupture are frequently observed. However, current treatment is l...
Autores principales: | Kallenbach, Klaus, Remes, Anca, Müller, Oliver J., Arif, Rawa, Zaradzki, Marcin, Wagner, Andreas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319421/ https://www.ncbi.nlm.nih.gov/pubmed/35887698 http://dx.doi.org/10.3390/jcm11143934 |
Ejemplares similares
-
AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome
por: Arif, Rawa, et al.
Publicado: (2017) -
The reimplantation valve-sparing aortic root replacement technique for patients with Marfan syndrome: A single-center experience
por: Kremer, Jamila, et al.
Publicado: (2019) -
Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy
por: Seppelt, Philipp Christian, et al.
Publicado: (2016) -
An integrative systems approach identifies novel candidates in Marfan syndrome‐related pathophysiology
por: Bhushan, Raghu, et al.
Publicado: (2019) -
AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts
por: Remes, Anca, et al.
Publicado: (2019)